| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/12/2007 | US7230139 Diterpenoid compounds, compositions thereof and their use as anti-cancer or anti-fungal agents |
| 06/12/2007 | US7230132 Aryl N-cyanoguanidines and methods related thereto |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230105 9-aminoacridine derivatives and process for the preparation thereof |
| 06/12/2007 | US7230096 derivatives of 3'-amino LacNAc for treatment of inflammation, septic shock, cancer, autoimmune diseases, rheumatoid arthritis and multiple schlerosis |
| 06/12/2007 | US7230088 Compounds for dual photodiagnosis and therapy |
| 06/12/2007 | US7230085 Anti-DOTA antibody |
| 06/12/2007 | US7230084 Therapeutic using a bispecific antibody |
| 06/12/2007 | US7230083 Genetic engineered vitronectin receptors; restenosis therapy, anticancer agents |
| 06/12/2007 | US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 06/12/2007 | US7230026 Selected fused pyrrolocarbazoles |
| 06/12/2007 | US7230021 Therapy for immunology sensitive disease; marine animal extract |
| 06/12/2007 | US7230015 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 06/12/2007 | US7230013 Administering taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions for inhibiting tumor growth |
| 06/12/2007 | US7230009 Pyridoxal analogues and methods of treatment |
| 06/12/2007 | US7229978 Chloromethylating an alcohol or phenol, especially camptothecin, propofol, etoposide, vitamin E, or cyclosporin A, and reacting the product with phosphoric acid in the presence of a base in a suitable polar aprotic solvent |
| 06/12/2007 | US7229974 Used to diagnose or treat cancer, restenosis, a disease caused by a virus, a disease affected by integrins or cell-cell adhesion receptor or a disease triggered by diffusible factors |
| 06/12/2007 | US7229969 Dipeptidyl peptidaseIV and alanyl-aminopeptidase inhibitors |
| 06/12/2007 | US7229822 Melanoma differentation associated gene-5 and vectors and cells containing same |
| 06/12/2007 | US7229780 Monoclonal antibody against ovarian carcinoma |
| 06/12/2007 | US7229770 YKL-40 as a marker and prognostic indicator for cancers |
| 06/12/2007 | US7229755 Isolating a biological specimen from a human; testing the specimen for an alteration in a human MSH2 nucleotide sequence or its expression product; comparing the results obtained with the results obtained from a wild type control |
| 06/12/2007 | US7229628 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/12/2007 | US7229624 Ordered molecular presentation of antigens, method of preparation and use |
| 06/12/2007 | US7229623 Her-2/neu fusion proteins |
| 06/12/2007 | US7229620 for radiolabeling proteins, peptides and ligands with therapeutic radioisotopes such that these radiolabeled agents may be administered directly to patients without the need for additional purification; for the treatment of cancer |
| 06/12/2007 | US7229607 Treatment of respiratory disease |
| 06/12/2007 | CA2393758C Unsaturated 14,15-cyclopropano-androstanes |
| 06/12/2007 | CA2354023C Phenylglycine derivatives |
| 06/12/2007 | CA2287257C 1,2,4-benzotriazine oxides formulations |
| 06/12/2007 | CA2214649C Antigen presenting system and methods for activation of t-cells |
| 06/12/2007 | CA2198005C Pyrazolo[3,4-g]quinoxaline compounds which inhibit pdgf receptor protein tyrosine kinase |
| 06/12/2007 | CA2173975C Recombinant adenoviral vector and methods of use |
| 06/12/2007 | CA2113712C Papilloma virus vaccine |
| 06/12/2007 | CA2072620C Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 06/12/2007 | CA1341530C Inhibitors of angiogenin |
| 06/07/2007 | WO2007065100A1 Pyrrolotriazine kinase inhibitors |
| 06/07/2007 | WO2007065023A2 Processes for obtaining lignan extracts and compositions containing the lignan extracts |
| 06/07/2007 | WO2007064993A2 Bicyclic protein kinase inhibitors |
| 06/07/2007 | WO2007064872A2 Urea compounds useful in the treatment of cancer |
| 06/07/2007 | WO2007064797A2 Inhibitors of c-met and uses thereof |
| 06/07/2007 | WO2007064753A2 Cancer treatment method |
| 06/07/2007 | WO2007064345A2 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 06/07/2007 | WO2007063946A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
| 06/07/2007 | WO2007063903A1 Novel peptide compound |
| 06/07/2007 | WO2007063293A1 Quinazoleine derivatives used as inhibitors of erbb tyrosine kinase |
| 06/07/2007 | WO2007063291A1 4-anilino-substituted quinazoline derivatives as tyrosine kinase inhibitors |
| 06/07/2007 | WO2007063124A1 Use of a compound comprising a camptothecin derivative for preparing pharmaceutical formulations useful in the treatment of melanoma |
| 06/07/2007 | WO2007063013A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents |
| 06/07/2007 | WO2007062875A1 Heteroaromatic sulfonamide prodrugs |
| 06/07/2007 | WO2007062805A1 3-(SUBSTITUTED AMINO)-PYRAZOLO[3,4-d]PYRIMIDINES AS EPHB AND VEGFR2 KINASE INHIBITORS |
| 06/07/2007 | WO2007062568A1 Compounds used as mammalian cell amp-activated protein kinase(ampk) activators and their preparation methods and usages |
| 06/07/2007 | WO2007062564A1 Lyophilized taxane-liposome composition and its preparing process |
| 06/07/2007 | WO2007062466A1 Demibodies: dimerisation-activated therapeutic agents |
| 06/07/2007 | WO2007062459A1 Selective kinase inhibitors based on pyridine scaffold |
| 06/07/2007 | WO2007048088A3 Method of inhibiting flt3 kinase |
| 06/07/2007 | WO2007044426A3 Pyrazolopyrimidines as protein kinase inhibitors |
| 06/07/2007 | WO2007044401A3 Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 06/07/2007 | WO2007043715A9 Rna-binding peptide |
| 06/07/2007 | WO2007042786A3 4 -heteroaryl pyrimidine derivatives and use thereof as protein kinase inhibitors |
| 06/07/2007 | WO2007038073A3 Mutations and polymorphisms of hdac11 |
| 06/07/2007 | WO2007024744A3 Heterocyclic carboxamide compounds as steroid nuclear receptor ligands |
| 06/07/2007 | WO2007015870A3 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 06/07/2007 | WO2007002258A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 06/07/2007 | WO2006113495A3 Dicarboxylic acid ester derivatives of ginsenoside, pharmaceutical preparations containing the same, and preparation thereof |
| 06/07/2007 | WO2006099313A3 Phosphate conjugates of prenylation inhibitors |
| 06/07/2007 | WO2006081331A3 Quinoxaline derivatives as antitumor agents |
| 06/07/2007 | WO2006042100A3 Method for the treatment of polycystic kidney disease |
| 06/07/2007 | WO2005016234A3 Compositions, methods, apparatuses, and systems for singlet oxygen delivery |
| 06/07/2007 | US20070129427 Novel compound and pharmaceutical composition |
| 06/07/2007 | US20070129411 Treatment of proliferative diseases with epothilone derivatives and radiation |
| 06/07/2007 | US20070129399 Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors |
| 06/07/2007 | US20070129365 6-Substituted pyridoindolone derivatives, production and therapeutic use thereof |
| 06/07/2007 | US20070129348 Receptor antagonist |
| 06/07/2007 | US20070129318 Antisense oligonucleotide having anticancerous activity |
| 06/07/2007 | US20070129317 Use of boswellic acid and its derivatives for inhibiting normal and increased leucocytic elastase or plasmin activity |
| 06/07/2007 | US20070129311 Compounds comprising two human GlxI inhibitors covalently linked via a diacid where each of the inhibitors may be the same or different and is an S-substituted glutathione or a prodrug thereof having a gamma-glutamyl amino group; length >50 Angstroms; antitumor, -carcinogenic, -proliferative agents |
| 06/07/2007 | US20070129300 Cytotoxic factors for modulating cell death |
| 06/07/2007 | US20070129289 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 06/07/2007 | US20070129285 Protein a compositions and methods of use |
| 06/07/2007 | US20070128695 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128645 Use of KIAA0172 gene in treatment and diagnosis of diseases as well as in pharmaceutical development |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128603 Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7) |
| 06/07/2007 | US20070128591 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/07/2007 | US20070128212 Ceramidase inhibitor |
| 06/07/2007 | US20070128207 Method of selecting wt1 vaccine adaptive patient |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |
| 06/07/2007 | US20070128202 inhibiting growth of cancerous cells using an antibody (mPA7) which binds to antigen CD46 which is present on a variety of human cancers from ovary, breast, lung, prostate, colon, kidney, and pancreas |
| 06/07/2007 | US20070128201 Combined use of ecteinascidin-743 and platinum antineoplastic compounds |
| 06/07/2007 | US20070128198 Compositions comprising antibodies to human fgl2 |
| 06/07/2007 | US20070128197 Monoclonal antibody or an antigen-binding fragment thereof which binds to human VEGF-B (vascular endothelial growth factor) produced by hybridoma; neovascularization diseases; antitumor, anticarcinogenic, antiinflammatory, and antimetastasis agents; rheumatoid arthritis; angiogenesis inhibitors |
| 06/07/2007 | US20070128192 Human antibody molecules for il-13 |
| 06/07/2007 | US20070128188 For stimulating release of tumor necrosis factor and/or cellular prolifefration/differentiation of chondrocytes by contacting blood w/polypeptide; diagnosis cancer |
| 06/07/2007 | US20070128115 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 06/07/2007 | US20070128112 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 06/07/2007 | US20070125613 Impact absorbent assembly in slope protection systems |
| 06/07/2007 | CA2657452A1 Immunoconjugate for human cd66 for the treatment of multiple myeloma and other haematological malignancies |
| 06/07/2007 | CA2632279A1 Heteroaromatic sulfonamide prodrugs |